Effective-Component Compatibility of Bufei Yishen Formula III Ameliorated COPD by Improving Airway Epithelial Cell Senescence by Promoting Mitophagy via the NRF2/PINK1 Pathway
Scientists investigated the mechanisms of effective-component compatibility of Bufei Yishen formula III in chronic obstructive pulmonary disease rats from the aspect of airway epithelial cell senescence.
[Prostate Cancer Foundation] The Prostate Cancer Foundation announced four inaugural Class of 2022 TACTICAL Award recipients. This $30 million program will support cross-disciplinary pioneering research toward the goal of developing 21st Century therapies for the most life-threatening form of prostate cancer.
[Nature Communications] Researchers reported high levels of androgen receptor chromatin binding heterogeneity in human primary prostate tumors, that overlapped with heterogeneity observed in healthy prostate epithelium.